ATE435871T1 - Methode zur bildung einen peptid-rezeptor komplex mit zsig33 polypeptiden. - Google Patents
Methode zur bildung einen peptid-rezeptor komplex mit zsig33 polypeptiden.Info
- Publication number
- ATE435871T1 ATE435871T1 AT00982197T AT00982197T ATE435871T1 AT E435871 T1 ATE435871 T1 AT E435871T1 AT 00982197 T AT00982197 T AT 00982197T AT 00982197 T AT00982197 T AT 00982197T AT E435871 T1 ATE435871 T1 AT E435871T1
- Authority
- AT
- Austria
- Prior art keywords
- forming
- receptor complex
- peptide receptor
- zsig33 polypeptides
- hormones
- Prior art date
Links
- 102000014187 peptide receptors Human genes 0.000 title abstract 2
- 108010011903 peptide receptors Proteins 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 239000005556 hormone Substances 0.000 abstract 2
- 229940088597 hormone Drugs 0.000 abstract 2
- 230000028327 secretion Effects 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000038379 digestive enzymes Human genes 0.000 abstract 1
- 108091007734 digestive enzymes Proteins 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 235000021231 nutrient uptake Nutrition 0.000 abstract 1
- 210000000496 pancreas Anatomy 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Transplantation (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16676599P | 1999-11-22 | 1999-11-22 | |
| PCT/US2000/032074 WO2001038355A2 (en) | 1999-11-22 | 2000-11-22 | Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE435871T1 true ATE435871T1 (de) | 2009-07-15 |
Family
ID=22604630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00982197T ATE435871T1 (de) | 1999-11-22 | 2000-11-22 | Methode zur bildung einen peptid-rezeptor komplex mit zsig33 polypeptiden. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7888056B2 (de) |
| EP (1) | EP1232175B1 (de) |
| JP (1) | JP4800537B2 (de) |
| AT (1) | ATE435871T1 (de) |
| AU (1) | AU1925701A (de) |
| CA (1) | CA2392019A1 (de) |
| DE (1) | DE60042527D1 (de) |
| WO (1) | WO2001038355A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1925701A (en) * | 1999-11-22 | 2001-06-04 | Zymogenetics Inc. | Method of forming a peptide-receptor complex with zsig33 |
| EP1556084A4 (de) * | 2002-10-07 | 2006-01-11 | Zymogenetics Inc | Verfahren zur regulierung deskörpergewichts |
| DE602004012207T2 (de) | 2003-10-16 | 2009-03-12 | F. Hoffmann-La Roche Ag | Fluoreszent markierte Ghrelin-Peptide |
| EP1524274B1 (de) * | 2003-10-16 | 2008-03-05 | F. Hoffmann-La Roche Ag | Fluoreszent markierte Ghrelin-Peptide |
| CA2939778C (en) | 2007-01-31 | 2019-01-29 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| CA2682174C (en) | 2007-03-28 | 2021-04-06 | President And Fellows Of Harvard College | Stitched polypeptides |
| KR20130099938A (ko) | 2010-08-13 | 2013-09-06 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| CN104039342A (zh) | 2011-10-18 | 2014-09-10 | 爱勒让治疗公司 | 拟肽大环化合物 |
| NZ627528A (en) | 2012-02-15 | 2016-05-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles |
| HK1205454A1 (en) | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| SG11201503052RA (en) | 2012-11-01 | 2015-05-28 | Aileron Therapeutics Inc | Disubstituted amino acids and methods of preparation and use thereof |
| MX2017003797A (es) | 2014-09-24 | 2017-06-15 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos y usos de los mismos. |
| WO2016154058A1 (en) | 2015-03-20 | 2016-09-29 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2315271C3 (de) | 1973-03-27 | 1975-09-11 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | L- Norleucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel |
| US5006469A (en) | 1988-02-09 | 1991-04-09 | Oregon Health Sciences University | Vectors and host cells expressing prepromotilin and motilin-associated peptide (MAP) |
| US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5470830A (en) | 1993-08-06 | 1995-11-28 | Ohmeda Pharmaceutical Products Division Inc. | Motilin-like polypeptides that inhibit gastrointestinal motor activity |
| WO1997021730A1 (en) * | 1995-12-13 | 1997-06-19 | Merck & Co., Inc. | Growth hormone secretagogue receptor family |
| US6380158B1 (en) | 1997-03-24 | 2002-04-30 | Zymogenetics, Inc. | Motilin homologs |
| US6291653B1 (en) | 1997-03-24 | 2001-09-18 | Zymogenetics, Inc. | Antibodies to motilin homologs |
| US6627729B1 (en) | 1997-03-24 | 2003-09-30 | Zymogenetics, Inc. | TML peptides |
| CA2284733C (en) * | 1997-03-24 | 2010-10-26 | Zymogenetics, Inc. | Motilin homologs |
| US6420521B1 (en) | 1999-06-30 | 2002-07-16 | Zymogenetics, Inc. | Short gastrointestinal peptides |
| CN101693736B (zh) | 1999-07-23 | 2020-09-11 | 寒川贤治 | 新的肽 |
| AU1925701A (en) | 1999-11-22 | 2001-06-04 | Zymogenetics Inc. | Method of forming a peptide-receptor complex with zsig33 |
| US6897286B2 (en) | 2000-05-11 | 2005-05-24 | Zymogenetics, Inc. | Zsig33-like peptides |
| US7392113B2 (en) * | 2005-02-08 | 2008-06-24 | Halliburton Energy Services, Inc. | Systems for controlling multiple actuators |
-
2000
- 2000-11-22 AU AU19257/01A patent/AU1925701A/en not_active Abandoned
- 2000-11-22 JP JP2001540118A patent/JP4800537B2/ja not_active Expired - Fee Related
- 2000-11-22 DE DE60042527T patent/DE60042527D1/de not_active Expired - Lifetime
- 2000-11-22 CA CA002392019A patent/CA2392019A1/en not_active Abandoned
- 2000-11-22 EP EP00982197A patent/EP1232175B1/de not_active Expired - Lifetime
- 2000-11-22 AT AT00982197T patent/ATE435871T1/de active
- 2000-11-22 WO PCT/US2000/032074 patent/WO2001038355A2/en not_active Ceased
-
2008
- 2008-06-26 US US12/147,187 patent/US7888056B2/en not_active Expired - Fee Related
-
2011
- 2011-01-28 US US13/016,537 patent/US8124356B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4800537B2 (ja) | 2011-10-26 |
| US7888056B2 (en) | 2011-02-15 |
| DE60042527D1 (de) | 2009-08-20 |
| WO2001038355A2 (en) | 2001-05-31 |
| CA2392019A1 (en) | 2001-05-31 |
| US20110151480A1 (en) | 2011-06-23 |
| EP1232175A2 (de) | 2002-08-21 |
| JP2003514917A (ja) | 2003-04-22 |
| US8124356B2 (en) | 2012-02-28 |
| AU1925701A (en) | 2001-06-04 |
| US20090081168A1 (en) | 2009-03-26 |
| WO2001038355A3 (en) | 2001-11-22 |
| EP1232175B1 (de) | 2009-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60042527D1 (de) | Methode zur bildung einen peptid-rezeptor komplex mit zsig33 polypeptiden. | |
| DE3855536D1 (de) | Rezeptoren für wachstumshormone | |
| MX2010005966A (es) | Conjugados de anticuerpo monoclonal-molecula asociada dirigidos a la proteina tirosina-cinasa 7 (ptk7). | |
| IL173559A0 (en) | Nogo receptor antagonists | |
| DE60333201D1 (de) | Verfahren zur herstellung von proteinen | |
| ATE501170T1 (de) | Verfahren zur herstellung humanisierter antikörper durch randomisierte mutagenese | |
| IL184112A0 (en) | A method for producing polypeptides or proteins in a disulfide-bridged two-chain form | |
| MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
| ATE457355T1 (de) | Verfahren und dna-konstrukte zur produktion von polypeptiden mit hoher ausbeute | |
| ATE368688T1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| DE60214400T8 (de) | Verfahren zur proteinproduktion in pflanzen | |
| DE59914490D1 (de) | Ein faktor viii-polypeptid mit faktor viii:c-aktivität | |
| DE60310385D1 (de) | Sekretion von proteinen mit mehreren disulfidbindungen in bakterien und verwendungen davon | |
| IS8339A (is) | Mótlyf viðtaka NOGO | |
| IL143558A0 (en) | Method of enhancing the biological activity of ligands | |
| ATE216723T1 (de) | Hormones de croissance humaines mutantes et leur utilisation | |
| IL113252A0 (en) | Eph receptors binding ligands | |
| DE60142511D1 (de) | Zsig33-ähnliche peptide | |
| BR0008187A (pt) | Controle biológico de nematódeos | |
| WO2009087173A3 (en) | Antibody designated barb3, barb3 related antibodies, and methods of making and using same | |
| TW200407428A (en) | Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof | |
| DE60333669D1 (de) | Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität | |
| WO2005066208A3 (en) | Method for production of recombinant growth hormone in form of hybrid protein | |
| WO2004089973A3 (en) | Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production | |
| AU4567501A (en) | Novel g-protein coupled receptors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1232175 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 1232175 Country of ref document: EP |